John Schilling MD Overview
- Firm
- TPG
- Primary Position
-
Partner & Lead...
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
John Schilling MD General Information
Biography
Dr. John Schilling serves as Partner & Lead of the Operations Team at TPG. Dr. Schilling serves as Chairman at Ellodi Pharmaceuticals. Dr. Schilling served as a Board Member at Adare Pharmaceuticals, AskBio, and BVI Medical. Previously, Dr. Schilling served as a Corporate Vice President of sales and Marketing at Abbott Laboratories. He co-leads the company's healthcare and operations teams. Earlier, he led Sales and Marketing for the U.S. pharmaceutical business at Abbott and was a Partner at McKinsey & Company. He received his undergraduate degree in Biomedical and Electrical Engineering from Duke, a Master's in Biomedical Engineering from Johns Hopkins where he was a Bozzelli Scholar, and an M.D. from the University of Chicago where he received the Joseph A. Capps Award for the most outstanding student in clinical medicine.
Contact Information
Address
- 888 7th Avenue
- 35th Floor
- New York, NY 10106
- United States
John Schilling MD Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| TPG | Investor | Partner & Lead of the Operations Team | Fort Worth, TX | PE/Buyout |
John Schilling MD Board Seats (3)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| BVI Medical | Surgical Devices | Privately Held (backing) | Private Equity-Backed | Waltham, MA | |
| Ellodi Pharmaceuticals | Drug Discovery | Privately Held (backing) | Private Equity-Backed | Blue Bell, PA | |
| Exactech | Surgical Devices | Privately Held (backing) | Formerly PE-Backed | Gainesville, FL |
John Schilling MD Lead Partner on Deals (6)
John Schilling MD has been the lead partner on 6 deals. Their latest deal was with Ellodi Pharmaceuticals, a drug discovery company. The deal was made on 22-Sep-2020.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Ellodi Pharmaceuticals | 22-Sep-2020 | Platform Creation | Completed | Drug Discovery | Blue Bell, PA | |
| RoverMed BioSciences | 17-Sep-2019 | Completed | Biotechnology | Saint Cloud, MN | ||
| Synpromics | 13-Aug-2019 | Completed | Biotechnology | United Kingdom | ||
| Asklepios BioPharmaceutical | 11-Apr-2019 | Completed | Drug Discovery | Durham, NC | ||
| Amneal Pharmaceuticals | 07-May-2018 | PIPE | Completed | Pharmaceuticals | Bridgewater, NJ | |
| CoPharma (United States) | 01-Apr-2014 | Buyout/LBO | Completed | Pharmaceuticals | Hopkinton, MA |
John Schilling MD Network (124)
Board Members (34)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Diana Nole | Exactech | Self | Gainesville, FL | |
| Bill Mitchell | Adare Pharma Solutions | Frazier Healthcare Partners | Lawrenceville, NJ | |
| BVI Medical | PhysIOL | Waltham, MA | ||
| Adare Pharma Solutions | Adare Pharma Solutions | Lawrenceville, NJ | ||
| Ellodi Pharmaceuticals | TPG | Blue Bell, PA |
Portfolio Executives (80)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Sarah Murchison | Ellodi Pharmaceuticals | Chief Operating Officer | 22-Sep-2020 | Blue Bell, PA |
| Troy Hamilton Ph.D | Ellodi Pharmaceuticals | Chief Executive Officer & Board Member | 22-Sep-2020 | Blue Bell, PA |
| RoverMed BioSciences | Chief Financial Officer | 17-Sep-2019 | Saint Cloud, MN | |
| RoverMed BioSciences | Chief Executive Officer & Board Member | 17-Sep-2019 | Saint Cloud, MN | |
| RoverMed BioSciences | Chairman | 17-Sep-2019 | Saint Cloud, MN |
Fund Team Members (10)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Michael McGinn | TPG | TSSP Structured Credit Opportunities Fund III | Fort Worth, TX |
| Michael McGinn | Sixth Street Partners | TSSP Structured Credit Opportunities Fund III | San Francisco, CA |
| TPG | Fort Worth, TX | ||
| TPG | Fort Worth, TX | ||
| TPG | Fort Worth, TX |
John Schilling MD Affiliated Funds (4)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| TPG Life Sciences Innovations Fund | TPG | Venture - General | Closed | 2023 | ||||
| TPG Energy Solutions Equity | TPG | Buyout | Closed | 2018 | ||||
| TPG Strategic Capital Fund | TPG | Growth/Expansion | Closed | 2021 | ||||
| TSSP Structured Credit Opportunities Fund III | TPG | Debt - General | Closed | 2020 |
John Schilling MD FAQs
-
Who is John Schilling MD?
Dr. John Schilling serves as Partner & Lead of the Operations Team at TPG.
-
How much does John Schilling MD typically invest?
John Schilling MD's median deal size is .
-
What is John Schilling MD’s main position?
John Schilling MD’s primary position is Partner & Lead of the Operations Team.
-
What are the contact details for John Schilling MD?
John Schilling MD’s email address is js and his phone number is +1 (212) .
-
How many active board seats does John Schilling MD hold?
John Schilling MD holds 3 board seats including BVI Medical, Ellodi Pharmaceuticals, and Exactech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
